|
Originally published In Press as doi:10.1074/jbc.M210375200 on December 6, 2002
J. Biol. Chem., Vol. 278, Issue 7, 4424-4430, February 14, 2003
Transient Mechanoactivation of Neutral Sphingomyelinase in
Caveolae to Generate Ceramide*
Malgorzata
Czarny ,
Jun
Liu §,
Phil
Oh, and
Jan E.
Schnitzer¶
From the Sidney Kimmel Cancer Center, Division of Vascular Biology
and Angiogenesis, San Diego, California 92121
The vascular endothelium acutely autoregulates
blood flow in vivo in part through unknown mechanosensing
mechanisms. Here, we report the discovery of a new acute
mechanotransduction pathway. Hemodynamic stressors from increased
vascular flow and pressure in situ rapidly and transiently
induce the activity of neutral sphingomyelinase but not that acid
sphingomyelinase in a time- and flow rate-dependent manner,
followed by the generation of ceramides. This acute mechanoactivation
occurs directly at the luminal endothelial cell surface primarily in
caveolae enriched in sphingomyelin and neutral sphingomyelinase, but
not acid sphingomyelinase. Scyphostatin, which specifically blocks
neutral but not acid sphingomyelinase, inhibits mechano-induced neutral
sphingomyelinase activity as well as downstream activation of
extracellular signal-regulated kinase 1 and 2 (ERK1 and ERK2) by
increased flow in situ. We postulate a novel physiological
function for neutral sphingomyelinase as a new mechanosensor initiating
the ERK cascade and possibly other mechanotransduction pathways.
*
This work was supported in part by National Institutes of
Health Grant HL67386 (to J. E. S.) and the Beth Israel Foundation. This
work was presented in part at the annual meeting of the Federation of
American Societies for Experimental Biology in San Diego, CA, April
15-18, 2000 (Liu, J., and Schnitzer, J. E. (2000) FASEB J. 14, A457 (abstr.)).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Joint first authors who contributed equally to this work.
§
Present address: Department of Physiology and Pharmacology and MBR
Cancer Center, West Virginia University School of Medicine, P. O. Box
9229, Morgantown, WV 26506.
¶
To whom correspondence should be addressed: Sidney Kimmel
Cancer Center, Division of Vascular Biology and Angiogenesis, 10835 Altman Row, San Diego, CA 92121. Tel.: 619-450-5990 (ext. 320); Fax:
619-450-3251; E-mail: jschnitzer@skcc.org.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Pavoine and F. Pecker
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Cardiovasc Res,
May 1, 2009;
82(2):
175 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Czarny and J. E. Schnitzer
Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium
Am J Physiol Heart Circ Physiol,
September 1, 2004;
287(3):
H1344 - H1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|